AFP subsidiary FACTSTORY co-produces documentary ‘Nigeria: Seeds of Hope’

FACTSTORY, an AFP subsidiary, has co-produced the documentary ‘Nigeria: Seeds of Hope’, directed by Judith Rueff and Moïse Gomis, in partnership with ARTE G.E.I.E. and France 24.

FACTSTORY, an AFP subsidiary, has co-produced the documentary ‘Nigeria: Seeds of Hope’, directed by Judith Rueff and Moïse Gomis, in partnership with ARTE G.E.I.E. and France 24.
Anglais
07/08/2025 12:00
Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical in the formation of neutralizing antibodies – for measles, mumps and rubella. This effort aims to build the most comprehensive understanding of the formation of neutralizing antibodies to the vaccine and to identify the dominant and effective antibodies to these infe...

07/08/2025 12:00
Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Novaliq”), a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, announce today that the China National Medical Products Administration (NMPA) has approved Heng Qin® (Perfluorohexyloctane Eye Drops) for the treatment of dry eye disease (DED) associated...

07/08/2025 12:00
ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth

ViaLase, Inc., a medical technology company pioneering noninvasive femtosecond laser treatments for glaucoma, today announced key changes to its executive leadership team as the company prepares for commercial launch and regulatory approvals in both the United States and Europe. Tibor Juhasz, PhD, founder and former Chief Executive Officer, has transitioned to the role of President and Chief Technology Officer, where he will continue to guide the company’s technological innovation roadmap. Sh...